Business Description
Aequus Pharmaceuticals Inc
NAICS : 325412
SIC : 3741
ISIN : CA0076361033
Compare
Compare
Traded in other countries / regions
AQS.CanadaAQSZF.USAAEQ.Germany IPO Date
2015-05-11Description
Aequus Pharmaceuticals Inc is a Canada-based specialty pharmaceutical company. The firm's operating segments are the Commercial platform and Development pipeline. It generates a majority of its revenue from the Commercial platform segment. The Company earns revenues from the sale of dry eye products and by providing promotional services to sell third-party-owned products, namely Tacrolimus IR and Vistitan.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.04 | |||||
| Equity-to-Asset | -3.06 | |||||
| Debt-to-Equity | -1.14 | |||||
| Debt-to-EBITDA | -2.42 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -49.08 | |||||
| Beneish M-Score | -8.17 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -20.6 | |||||
| 3-Year EBITDA Growth Rate | 9.8 | |||||
| 3-Year EPS without NRI Growth Rate | 22.2 | |||||
| 3-Year FCF Growth Rate | 9.1 | |||||
| 3-Year Book Growth Rate | 3.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 0.38 | |||||
| 9-Day RSI | 3.35 | |||||
| 14-Day RSI | 8.39 | |||||
| 6-1 Month Momentum % | -51.04 | |||||
| 12-1 Month Momentum % | -43.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.12 | |||||
| Quick Ratio | 0.07 | |||||
| Cash Ratio | 0.04 | |||||
| Days Inventory | 752.12 | |||||
| Days Sales Outstanding | 201.24 | |||||
| Days Payable | 1292.25 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -18.1 | |||||
| Shareholder Yield % | -54.42 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 83.33 | |||||
| Operating Margin % | -302.27 | |||||
| Net Margin % | -460.86 | |||||
| FCF Margin % | -509.93 | |||||
| ROA % | -98.9 | |||||
| ROIC % | -33.93 | |||||
| ROC (Joel Greenblatt) % | -179.9 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 5 | |||||
| EV-to-EBIT | -3.37 | |||||
| EV-to-EBITDA | -3.51 | |||||
| EV-to-Revenue | 14.95 | |||||
| EV-to-FCF | -3.03 | |||||
| Earnings Yield (Greenblatt) % | -29.67 | |||||
| FCF Yield % | -98.09 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:AQSZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aequus Pharmaceuticals Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.292 | ||
| EPS (TTM) ($) | -0.007 | ||
| Beta | 0.09 | ||
| Volatility % | 84.78 | ||
| 14-Day RSI | 8.39 | ||
| 14-Day ATR ($) | 0.000199 | ||
| 20-Day SMA ($) | 0.011218 | ||
| 12-1 Month Momentum % | -43.89 | ||
| 52-Week Range ($) | 0.0079 - 0.04 | ||
| Shares Outstanding (Mil) | 132.63 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aequus Pharmaceuticals Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aequus Pharmaceuticals Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aequus Pharmaceuticals Inc Frequently Asked Questions
What is Aequus Pharmaceuticals Inc(AQSZF)'s stock price today?
The current price of AQSZF is $0.01. The 52 week high of AQSZF is $0.04 and 52 week low is $0.01.
When is next earnings date of Aequus Pharmaceuticals Inc(AQSZF)?
The next earnings date of Aequus Pharmaceuticals Inc(AQSZF) is .
Does Aequus Pharmaceuticals Inc(AQSZF) pay dividends? If so, how much?
Aequus Pharmaceuticals Inc(AQSZF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers